Most cancers become deadly by keeping a low profile, causing no symptoms until they’re too advanced to treat. Ovarian and gastroesophageal cancers are among the most notorious for this sly disease progression, often leading to late-stage diagnoses. Now, an international team of researchers, including some from The Rockefeller University’s Laboratory of Cellular and Structural Biology, have developed a highly sensitive blood test that can detect a key protein produced by cancer cells that shows promise for early detection. The results were published on September 12, 2023 in Cancer Discovery. The open-access article is titled “Ultrasensitive Detection of Circulating LINE-1 ORF1p As a Specific Multi-Cancer Biomarker.”
Login Or Register To Read Full Story